Abstract: A medicine compounding system has a plurality of containers for containing medical compounds to be used to make up a medicine. A dosing chamber is connected to each of the plurality of containers and a drawing mechanism is used to draw compounds from the plurality of containers to the dosing chamber. A controller receives a script via a communications module which includes details of a patient and a medicine to be dispensed. The controller determines from the script which medical compounds and what quantities of each compound are to be used to form the medicine. The controller controls the drawing mechanism to draw the determined quantity of the medical compound from the container holding the compound into the dosing chamber, and once all of the required medical compounds have been drawn into the chamber to form the medicine, to eject the medicine formed in the dosing chamber via an outlet.

Abstract: The present invention relates to anti-cancer compositions based on extracts of a plant from the Mesembryanthemaceae family, in particular Mesembryanthemum tortuosum (Sceletium tortuosum), their use in the treatment of cancer, and methods of manufacturing the compositions. The anti-cancer compositions of the present invention include ?7 mesembrenone.

Abstract: The present invention relates to anti-cancer compositions based on extracts of a plant from the Mesembryanthemaceae family, in particular Mesembryanthemum tortuosum (Sceletium tortuosum), their use in the treatment of cancer, and methods of manufacturing the compositions. The anti-cancer compositions of the present invention include ?7 mesembrenone.

Abstract: The present invention relates to anti-cancer compositions based on extracts of a plant from the Mesembryanthemaceae family, in particular Mesembryanthemum tortuosum (Sceletium tortuosum), their use in the treatment of cancer, and methods of manufacturing the compositions. The anti-cancer compositions of the present invention include ?7 mesembrenone.

Abstract: A composition comprises as active ingredient an extract of a plant or plants from the Mesembryanthemaceae family, such as Mesembryanthemum tortuosum, having an alkaloid profile comprising at least 70% (w/w) stabilized mesembrine. The extracts from Mesembryanthemum tortuosum having an alkaloid profile comprising at least about 70% (w/w) stabilized mesembrine, about 20% (w/w) mesembrenone and about 10% (w/w) ?7 mesembrenone act as bioamine releasing agents, in particular as monoamine releasing agents, useful in the treatment of diseases and conditions responsive to treatment with a monoamine releasing agent, for instance diseases and conditions responsive to treatment with a serotonin-releasing agent.